Peroxisome Proliferator-Activated Receptors in Lung Cancer
2007

Peroxisome Proliferator-Activated Receptors in Lung Cancer

publication Evidence: moderate

Author Information

Author(s): Keshamouni Venkateshwar G., Han ShouWei, Roman Jesse

Primary Institution: University of Michigan, Emory University, Atlanta Veterans Affairs Medical Center

Hypothesis

Are PPARs potential therapeutic targets for lung cancer treatment?

Conclusion

PPAR-γ activation is associated with decreased lung carcinoma cell proliferation and may serve as a therapeutic target.

Supporting Evidence

  • PPAR-γ ligands induce growth arrest and promote apoptosis in lung carcinoma cell lines.
  • Activation of PPAR-γ is correlated with tumor histological type and grade.
  • PPAR-γ ligands can inhibit angiogenesis and tumor vascularization.

Takeaway

PPARs are proteins that can help control cancer growth, and scientists are studying how they might be used to treat lung cancer.

Methodology

This review summarizes existing research on PPARs and their role in lung cancer biology.

Limitations

The roles of PPAR-α and PPAR-β/δ in lung cancer remain uncertain and require further investigation.

Digital Object Identifier (DOI)

10.1155/2007/90289

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication